Oxford-based start-up Ultromics has announced the appointment of Amir Hasan as Chief Commercial Officer. Amir previously worked as Global Head of Cardiology Informatics at Philips.
16th October, Oxford, U.K., Oxford-based start-up Ultromics has announced the appointment of Amir Hasan as Chief Commercial Officer. Amir previously worked as Global Head of Cardiology Informatics at Philips. He joins the company after 19 years with Philips working in the UK, Netherlands, Silicon Valley and China. His immense experience – spanning from Business Development, Sales, and Marketing to driving next-generation informatics solutions for cardiac care – is the perfect fit for Ultromics.
As Chief Commercial Officer at Ultromics, Amir will report directly to the founder and CEO, Ross Upton. Amir will be responsible for driving the global sales and marketing strategy, as well as developing new business and managing revenue.
Ross Upton, the CEO and Academic Co-founder of Ultromics, expressed his enthusiasm for Amir’s appointment, “Amir brings a keen eye for innovation and a pragmatic mindset. His almost two decades of experience in healthcare-technology is an incredible asset, and we can’t wait to work with him on rolling out our products.”
Amir said “With Ultromics I see a golden opportunity to dramatically improve cardiac care delivery, leveraging AI technologies to support clinicians in the diagnosis of cardiac disease which will have a considerable impact on patients’ lives. We are an ambitious start-up and growing fast. My focus will be introducing a new product, a new business model and driving customer awareness and adoption to ensure we succeed.
“Our founders are a true inspiration. They had the foresight to collect outcomes data to build a strong evidence-base for the algorithms which form the basis of the EchoGo platform. This platform is ground-breaking in helping to make cardiovascular disease diagnosis much more accurate, and I strongly believe it will transform cardiology care”, Amir added.
Other new appointments include Chief Operations Officer, Nancy Spagou, who is driving the operations strategy and developing the delivery and deployment of Ultromics’ technology in clinical settings.
Ultromics has also seen over 15 new hires over the last 6 months within Product Management, Clinical Project Management, Regulatory and Research.
Ultromics is the start-up behind the world’s first outcomes-driven, AI-based, ultrasound diagnostic tool for coronary artery disease (CAD).
ENDS
About Ultromics
Ultromics is focused on bringing the benefits of AI to support clinicians in the diagnosis of cardiovascular disease, the largest cause of death globally. We develop echo-based tools by combining deep clinical insight with machine learning and some of the largest echo datasets in the world. The revolutionary platform provides data to aid clinicians in their diagnoses, without disrupting clinical workflow, whilst reducing burden and allowing more time with patients..
For more information please contact:
Sarah Jackson
| Digital Marketing Specialist | |
| Mobile: 07725321363 | |
